Changing epidemiology of group B streptococcal colonization

Pediatrics

Volumn 104, Issue 2 I, 1999, Pages 203-209

  Hickman, Melissa E ^a   Rench, Marcia A ^a   Ferrieri, Patricia ^b   Baker, Carol J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Antibiotics; Colonization; Group B Streptococcus; Intrapartum; Neonate; Serotype; Vertical

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; ANTIGEN; PENICILLIN G; PROTEIN C;

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CESAREAN SECTION; HUMAN; MEMBRANE RUPTURE; NEWBORN; PREVALENCE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; VERTICAL TRANSMISSION;

ANTIBIOTIC PROPHYLAXIS; CROSS-SECTIONAL STUDIES; DISEASE TRANSMISSION, VERTICAL; FEMALE; HUMANS; INFANT, NEWBORN; MINNESOTA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

EID: 0032812805     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.104.2.203     Document Type: Article

References (24)

1. Schuchat A. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev. 1998;11:497-513
2. Schuchat A, Deaver-Robinson K, Plikaytis BD, Zangwill KM, Mohle-Boetani J, Wenger JD. Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. Pediatr Infect Dis J. 1994;13:623-629
3. Baker CJ. Group B streptococcal infections. Clin Perinatol. 1997;24:59-70
4. Baker CJ, Barrett FF. Transmission of group B streptococci among parturient women and their neonates. J Pediatr. 1973;83:919-924
5. Anthony BF, Okada DM, Hobel CJ. Epidemiology of the group B streptococcus: maternal and nosocomial sources for infant acquisitions. J Pediatr. 1979;95:431-436
6. Ancona RJ, Ferrieri P, Williams PP. Maternal factors that enhance the acquisition of group B streptococci by newborn infants. J Med Microbiol. 1980;13:273-280
7. Boyer KM, Gotoff SP. Prevention of early-onset early B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med. 1986;134:1665-1669
8. Jelinkova J, Motlova J. Worldwide distribution of two new serotypes of group B streptococci: type IV and provisional type V. J Clin Microbiol. 1985;21:361-362
9. Rench MA, Baker CJ. Neonatal sepsis caused by a new group B streptococcal serotype. J Pediatr. 1993;122:638-641
10. Lin F-Y C, Clemens JD, Azimi PH, et al. Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infection. J Infect Dis. 1998;177:790-792
11. Lachenauer CS, Kasper DL, Shimada J, et al. Serotypes VI and VII predominate among group B streptococci isolated from pregnant Japanese women. Presented at the Program and Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. 1997;318:K80
12. American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. Guidelines for prevention of early-onset group B streptococcal infection. Pediatrics. 1992;90:775-778
13. Schuchat A, Whitney C, Zangwill KM. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Morbid Mortal Weekly Rep. 1996;45:1-24
14. American Academy of Pediatrics, Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised guidelines for prevention of early-onset group B streptococcal infection. Pediatrics. 1997;99: 489-495
15. Zaleznik DF, Krohn MA, Hillier SL, et al. Group B streptococcal colonization in parturient women differs among racial groups. Presented at the Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. 1995;322:K188
16. Johnson DR, Ferrieri P. Group B streptococcal Ibc protein antigen: distribution of two determinants in wild-type strains of common serotypes. J Clin Microbiol. 1984;19:506-510
17. Pass MA, Gray BM, Khare S, Dillon HC Jr. Prospective studies of group B streptococcal infections in infants. J Pediatr. 1979;95:437-443
18. Ferrieri P, Cleary PP, Seeds AE. Epidemiology of group-B streptococcal carriage in pregnant women and newborn infants. J Med Microbiol. 1977;10:103-114
19. Cueto M, Sanchez MJ, Sampedro A, et al. Relationship between timing of intrapartum ampicillin administration and its effectiveness in preventing vertical transmission of group B streptococci. Presented at the Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. 1995;323:K193
20. Pylipow M, Gaddis M, Kinney JS. Selective intrapartum prophylaxis for group B Streptococcus colonization: management and outcome of newborns. Pediatrics. 1994;93:631-635
21. Centers for Disease Control and Prevention. Decreasing incidence of perinatal group B streptococcal disease - United States 1993-1995. MMWR Morbid Mortal Weekly Rep. 1997;46:473-477
22. Centers for Disease Control and Prevention. Adoption of hospital policies for prevention of perinatal group B streptococcal disease - United States, 1997. MMWR Morbid Mortal Weekly Rep. 1998;47:665-670
23. Harrison LH, Elliott JA, Dwyer DM, et al. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. J Infect Dis. 1998;177:998-1002
24. Kasper DL, Paoletti LC, Wessels MR, et al. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest. 1996;98:2308-2314